Zobrazeno 1 - 10
of 22
pro vyhledávání: '"35"'
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 12:434-439
Objective Morbid obesity (body mass index S 35 kg/m2)usually confers a higher perioperative risk in cardiac surgery. Robotic cardiac surgery may have many advantages for these high-risk patients. Methods We retrospectively reviewed patients undergoin
Autor:
Masaki Funamoto, Edward Soltese, Scott C. Silvestry, George Batsides, Elias Zias, David A. D'Alessandro, Masahiro Ono, Anthony Lemaire, Danny Ramzy, Mark E. Anderson
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 16:365-372
Objective To report the initial clinical experience with the Impella 5.5® with SmartAssist®, a temporary left ventricular assist device that provides up to 6.2 L/min forward flow, with recent FDA approval for up to 14 days. Methods From October 201
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 14:209-217
Objective To assess early and late clinical outcomes in patients who underwent aortic valve repair surgery for aortic valve insufficiency, and to investigate predictors for recurrence. Methods Of 151 consecutive patients who underwent aortic valve re
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 10 (2020)
Pulmonary Circulation, Vol 10 (2020)
The renin–angiotensin–aldosterone system is implicated in the pathophysiology of pulmonary arterial hypertension. We undertook this study to determine the effects of spironolactone, a mineralocorticoid receptor blocker, on collagen metabolism in
Autor:
Richard B. Schuessler, Spencer J. Melby, Vivek Hansalia, Farah N. Musharbash, Matthew R. Schill, Jeremy E. Leidenfrost, Ralph J. Damiano
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 13:261-266
Objective Septal myectomy remains the criterion standard for the treatment of patients with hypertrophic obstructive cardiomyopathy refractory to medical therapy. There have been few reports of minimally invasive approaches. This study compared a min
Autor:
Danny Ramzy, Joseph M. Massaro, Mark B. Anderson, Anson Cheung, Edward G. Soltesz, George Batsides
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 13:254-260
Objective The aim of the study was to comprehensively summarize the survival outcomes and complications of Impella 5.0 (Abiomed Inc, Danvers, MA USA) use in patients with cardiogenic shock (CS). Methods We performed a literature review for relevant s
Autor:
Masaru Kimura, Toshiaki Watanabe, Katsuyuki Hoshina, Marie Ohshima, Sota Yamamoto, Masaharu Kobayashi
Publikováno v:
Asian Cardiovascular and Thoracic Annals. 26:133-138
Background Considering the unique characteristics of splenic artery aneurysms, we hypothesized that hemodynamic forces could play an important role in splenic artery aneurysm formation and that splenic artery geometry should be correlated with aneury
Autor:
Seung-Ill Park, Junhee Han, Kanghoon Lee, Hyeong Ryul Kim, Se Hoon Choi, Dong Kwan Kim, Yong-Hee Kim
Publikováno v:
Asian Cardiovascular and Thoracic Annals. 25:623-629
Background The aim of this retrospective study was to review recurrence patterns of stage I non-small-cell lung cancer and identify prognostic factors for post-recurrence survival. Methods Among 940 patients with pathological stage I non-small-cell l
Publikováno v:
Pulmonary Circulation
Once initiated for pulmonary arterial hypertension (PAH), epoprostenol treatment usually needs to be delivered for an indefinite duration. It is possible that some participants could be transitioned from epoprostenol to oral therapies. We retrospecti
Autor:
Daniel Ocazionez, Matthew D. Terwelp, Richard W. Smalling, Yelin Zhao, Tom C. Nguyen, Vinod H. Thourani, Anthony L. Estrera, Catalin Loghin, Justin Q. Pham, Prakash Balan, Joseph Lamelas
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 12:33-40
Objective Low ejection fraction (EF < 40%) portends adverse outcomes in patients undergoing valvular heart surgery. The role of traditional median sternotomy aortic valve replacement (SAVR) compared with minimally invasive aortic valve replacement (M